<DOC>
	<DOCNO>NCT01424111</DOCNO>
	<brief_summary>The purpose research explore objective biomarkers voice , physiological , motor , brain imaging signal may one day use complement clinical evaluation treatment depression .</brief_summary>
	<brief_title>Exploring Biomarkers Depression</brief_title>
	<detailed_description>The hypothesis work dynamical fluctuation biological signal , , voice , video , pulse rate , oxygen saturation , skin temperature , skin conductivity , motor response , magnetoencephalography ( MEG ) , electroencephalography ( EEG ) , less complex depressive normal phase . There great need objective biomarkers may complement current clinical measure help recognize depression , monitor severity , quantify effect intervention recovery . Data collect 20 adult participant seek outpatient treatment depression Depression Clinical Research Program Massachusetts General Hospital ( MGH ) , participate total approximately 9 week . For correlation finding , data also collect 20 subject take part healthy/control group . The healthy/control group participate limit study visit schedule course 9 week , give treatment . During study visit , investigator conduct recording voice , video , pulse rate , oxygen saturation , body temperature , skin conductivity , motor movement Department Psychiatry MGH . In addition , subject may participate MEG , EEG , Magnetic Resonance Imaging ( MRI ) brain imaging session Athinoula A. Martinos Center Biomedical Engineering . In order collect relevant data correlate finding accept clinical measure depression severity response treatment , study conduct follow-up study concert typical drug treatment protocol Major Depressive Disorder ( MDD ) . Specifically , measurement make conjunction standard care drug treatment protocol use antidepressant medication escitalopram , FDA-approved selective serotonin re-uptake inhibitor ( SSRI ) commonly use treat depression . The data collect period approximately 9 week .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Treatment Group 1 . Men woman age 1865 ; 2 . Written informed consent ; 3 . Meet DSMIV criterion ( Structured Clinical Interview DSMIV SCIDI/P ) current major depressive episode ( MDE ) ; 4 . Hamilton Rating Scale Depression ( HAMD17 ) baseline score ≥ 16 . Treatment Group 1 . Subjects whose first language English ; 2 . In woman , pregnancy , plan conceive , unwillingness comply birth control requirement ; 3 . Subjects baseline Clinical Global ImpressionsSeverity score 6 7 ; 4 . Subjects suicidal ideation outpatient treatment determine unsafe clinician . These subject immediately refer appropriate clinical treatment ; 5 . Serious unstable medical illness , include cardiovascular , hepatic , renal , respiratory , endocrine , neurologic hematologic disease ; 6 . History seizure disorder ; 7 . History current diagnosis follow DSMIV psychiatric illness : organic mental disorder , schizophrenia , schizoaffective disorder , delusional disorder , psychotic disorder otherwise specify , bipolar disorder , patient mood congruent mood incongruent psychotic feature , patient substance dependence disorder , include alcohol , active within last 12 month ; 8 . Subjects mood congruent mood incongruent psychotic feature ; 9 . Clinical laboratory evidence hypothyroidism ; 10 . Positive urine drug screen evaluation visit ; 11 . Electro Convulsive Therapy ( ECT ) last year ; 12 . Subjects fail respond course current major depressive episode trial escitalopram ( least 40mg/day six week ) 13 . History intolerance citalopram escitalopram ; 14 . Subjects require exclude medication include antidepressant , anorexic , antiarrhythmic , psychotropic agent ( include lithium , benzodiazepine sedative , sedative , antiseizure medication ) , betablockers ( metoprolol propranolol ) ketoconazole , itraconazole , fluconazole , erythromycin , omeprazole , cimetidine , dehydroepiandrosterone ( DHEA ) , entacapone , hydroxytryptophan ( 5HTP ) , ginkgo , St. John 's Wort ( hypercium ) , naratriptan , rizatriptan , sibutramine , zolmitriptan warfarin ( Coumadin ) . 15 . Subjects fail two adequate antidepressant trial current Major Depressive Episode ( MDE ) If subject deem eligible criterion , additional exclusion criterion require participate Martinos Center study visit , list . Subjects meet criterion allow participate visit Martinos Center . 16 . Subjects weight 300 lb . ( limit 1.5T Siemens Sonata whole body scanner use MRI data acquisition ) ; 17 . History significant head trauma ( unconsciousness 10 minute longer ) ; 18 . Surgical aneurysm clip ; 19 . Cardiac pacemaker ; 20 . Prosthetic heart valve ; 21 . Use neurostimulator ; 22 . Implanted pump ; 23 . Cochlear implant ; 24 . Metal rod , plate , screw body , metal foil medical skin patch remove ; 25 . IUD ; 26 . Previous head surgery ; 27 . Hearing aid ; 28 . Nonremovable denture , root canal , dental implant , bridge , wire mouth ; 29 . Currently breastfeed ; 30 . Meniere 's Disease ; 31 . Metal ( shiny ) tattoo metal body jewelry remove ; 32 . Claustrophobia ; 33 . Abnormal hearing ; 34 . Glasses vision correction great +/ 6 diopter . Healthy/Control Group 1 . Men Women , age 1865 ; 2 . Written informed consent ; 3 . QIDSSR score &lt; 8 Screening Visit ; 4 . Agrees , eligible , biomarkers procedure ( M/EEG , MRI , physiological recording ) ; Healthy/Control Group 1 . Subjects whose first language English ; 2 . Current lifetime history major depressive disorder , psychotic depression bipolar ( I , II , NOS ) disorder , schizoaffective disorder , schizophrenia , Axis I psychotic disorder ; 3 . Meet DSMIV criterion ( Structured Clinical Interview DSMIV SCIDI/P ) current major depressive episode ( MDE ) ; 4 . HAMD17 baseline score ≥ 8 5 . Any current Axis I Axis II diagnose ; 6 . A woman pregnant breastfeeding ; 7 . Meeting DSMIV criterion substance dependence last 6 month , except nicotine , substance abuse last 2 month ; 8 . Positive urine drug screen evaluation visit ; 9 . Any current history unstable general medical condition ( GMC ) require hospitalization deem investigator clinically significant ; 10 . Any current history moderate severe acute chronic medical condition , base judgment PI appropriate medical personnel would exclude subject i.e . epilepsy , unstable hypothyroidism ; If subject deem eligible criterion , additional exclusion criterion require participate Martinos Center study visit . Subjects meet criterion allow participate visit Martinos Center : 11 . Subjects weight 300 lb . ( limit 1.5T Siemens Sonata whole body scanner use MRI data acquisition ) ; 12 . History significant head trauma ( unconsciousness 10 minute longer ) ; 13 . Surgical aneurysm clip ; 14 . Cardiac pacemaker ; 15 . Prosthetic heart valve ; 16 . Use neurostimulator ; 17 . Implanted pump ; 18 . Cochlear implant ; 19 . Metal rod , plate , screw body , metal foil medical skin patch remove ; 20 . IUD ; 21 . Previous head surgery ; 22 . Hearing aid ; 23 . Nonremovable denture , root canal , dental implant , bridge , wire mouth ; 24 . Currently breastfeed ; 25 . Meniere 's Disease ; 26 . Metal ( shiny ) tattoo metal body jewelry remove ; 27 . Claustrophobia ; 28 . Abnormal hearing ; 29 . Glasses vision correction great +/ 6 diopter .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Biomarkers</keyword>
	<keyword>Depression</keyword>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Escitalopram</keyword>
</DOC>